Early stage high risk ER+/HER2- Breast Cancer
Dr. Nick Zdenkowski discusses a case of early-stage, high-risk breast cancer, detailing the patient’s diagnosis, treatment plan, and outcomes.
December 13 – Dr. Nicholas Zdenkowski
Dr. Nick Zdenkowski discusses tumor-infiltrating lymphocytes as prognostic and predictive factors in breast cancer.
December 13 – Dr. Virginia Kaklamani
Dr. Virginia Kaklamani discusses the PATINA trial, a phase III clinical trial.
December 13 – Dr. Nicholas Zdenkowski
Dr. Nick Zdenkowski discusses resistance mechanisms to CDK4/6 inhibitors.
December 13 – Dr. Virginia Kaklamani
Dr. Virginia Kaklamani highlights the EMBER-3 clinical trial, which found that imlunestrant outperformed single-agent endocrine therapy in patients with ESR1 mutations and showed improvement when combined with abemaciclib, suggesting potential FDA approval.
December 12 – Dr. Carlos Barrios
Dr. Carlos Barrios discusses the PATINA trial that was presented recently.
December 12 – Dr. Sherene Loi
Dr. Sherene Loi discusses the development and importance of immune biomarkers in breast cancer, highlighting the TIL biomarker, the limitations of PD-L1, and the potential of new biomarkers to refine treatment algorithms and clinical trials
December 11 – Dr. Nicholas Zdenkowski
Dr. Nick Zdenkowski discusses the EMBER trial on second-line ER-targeted drugs, patient-reported outcome monitoring, and the survival benefits of risk-reducing surgeries for BRCA mutant patients.
December 10 – Dr. Nicholas Zdenkowski
Dr. Nicholas Zdenkowski informs us that the authors presented their priorities in breast cancer, focusing on shared decision-making, optimizing multidisciplinary consultation, and improving data on metastatic breast cancer to better care for these patients.
San Antonio Breast Cancer Symposium 2024
Video highlights from the San Antonio Breast Cancer Symposium (SABCS) 2024, taking place in San Antonio, TX from December 10 to 13, 2024.
Dr. Sabanathan Case Study
Dr. Dhanusha Sabanathan, a medical oncologist from Sydney, presents cases of metastatic breast cancer, highlighting the effectiveness of the latest medications in treating metaplastic triple-negative breast cancer with minimal side effects.
(ESMO) European Society for Medical Oncology conference highlights
Video highlights from the European Society for Medical Oncology (ESMO) Conference 2024, taking place in Barcelona from September 13 to September 17.
These clips will provide invaluable insights and updates on Breast Cancer research from ESMO 2024.
Stay tuned for more details and expert presentations!
Independent highlights of American Society of Clinical Oncology Conference 2024
• Latest research highlights from the American Society of Clinical Oncology Annual Meeting 2024
• Exclusive insights provided by our esteemed experts Dr. Roland CY Leung, Dr. Chun-Yu Liu, Prof. Sherene Loi, Prof. Nick Zdenkowski and Dr. Dhanusha Sabanathan
• Explore these highlights to enhance your clinical practice and stay updated on the latest advancements
SABCS Symposium 2023 Highlights
• Latest research highlights from the 2023 edition of the San Antonio Breast Cancer Symposium
• Exclusive insights provided by our esteemed experts Dr. Roland CY Leung, Dr. Chun-Yu Liu, Prof. Sherene Loi, Prof. Bruce Mann and Prof. Nick Zdenkowski
• Explore these highlights to enhance your clinical practice and stay updated on the latest advancements
Overview of the prevalence and clinical landscape of Breast Cancer
VIDEO ABSTRACT
• Overview of the prevalence and clinical landscape of Breast Cancer (BC), with a focused mention of the Asia Pacific region
• Overview of the subtypes and risk factors associated with BC, the predictive models of assessing the risk of developing BC as well as diagnostic approaches and major treatment strategies of BC
• Also emphasizes the need and means of early detection of BC for better clinical outcomes